QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Alkermes
(NASDAQ:ALKS)
29.69
00
At close: May 17
29.69
00
PreMarket: 4:55PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low21.24 - 33
Open / Close- / -
Float / Outstanding123.5M / 163.4M
Vol / Avg.- / 1.6M
Mkt Cap4.9B
P/E-
50d Avg. Price27.54
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float123.5M

Alkermes (NASDAQ:ALKS), Quotes and News Summary

Alkermes (NASDAQ: ALKS)

Day High/Low- - -
52 Week High/Low21.24 - 33
Open / Close- / -
Float / Outstanding123.5M / 163.4M
Vol / Avg.- / 1.6M
Mkt Cap4.9B
P/E-
50d Avg. Price27.54
Div / Yield-
Payout Ratio-
EPS-0.22
Total Float123.5M
Benzinga - Apr 28, 2022, 6:33AM
Benzinga - Apr 28, 2022, 6:05AM
Benzinga - Apr 27, 2022, 10:17AM
Benzinga - Apr 27, 2022, 7:07AM
Benzinga - Apr 21, 2022, 9:49AM
Benzinga - Apr 20, 2022, 6:12AM
Benzinga - Apr 19, 2022, 3:25PM
Benzinga - Apr 19, 2022, 7:39AM
Benzinga - Sponsored
Benzinga - Sponsored
Benzinga - Mar 22, 2022, 8:50AM
Benzinga - Mar 1, 2022, 7:17AM
Benzinga - Feb 17, 2022, 11:23AM
Benzinga - Feb 17, 2022, 7:24AM
Benzinga - Feb 16, 2022, 1:51PM
Benzinga - Feb 16, 2022, 10:10AM
Benzinga - Feb 16, 2022, 9:36AM
load more
Sector: Health Care.Industry: Biotechnology
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-27
REV
Q1 2022Est.ActualSurprise
EPS0.0100.120 0.1100
REV252.590M278.545M25.955M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Alkermes Questions & Answers

Q
How do I buy Alkermes (ALKS) stock?
A

You can purchase shares of Alkermes (NASDAQ: ALKS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Alkermes's (ALKS) competitors?
Q
What is the target price for Alkermes (ALKS) stock?
A

The latest price target for Alkermes (NASDAQ: ALKS) was reported by SVB Leerink on Thursday, April 28, 2022. The analyst firm set a price target for 27.00 expecting ALKS to fall to within 12 months (a possible -9.06% downside). 14 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Alkermes (ALKS)?
A

The stock price for Alkermes (NASDAQ: ALKS) is $29.69 last updated May 17, 2022, 8:00 PM UTC.

Q
Does Alkermes (ALKS) pay a dividend?
A

There are no upcoming dividends for Alkermes.

Q
When is Alkermes (NASDAQ:ALKS) reporting earnings?
A

Alkermes’s Q2 earnings are confirmed for Wednesday, July 27, 2022.

Q
Is Alkermes (ALKS) going to split?
A

There is no upcoming split for Alkermes.

Q
What sector and industry does Alkermes (ALKS) operate in?
A

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.